If PPS remained stagmant for 2 years then we would literally be funding a plethora of trials strictly through dilution. It would severely damage your long term investment if not bankrupt the company. IMO shareprice will remain stagnant until EOY which is disappointing. CEO made me feel we were closer to significant non dil financing. That being said still think upside is greater and I am still here. Not confident enough though to consider these levels a gift at this point.